News Releases

April 5, 2022 at 11:00 AM EDT

Summary Toggle Financial Times Ranks OptimizeRx Amongst Americas’ Fastest-Growing Companies for the Third Consecutive Year

OptimizeRx grew 2021 revenue by 42% year-over-year, spotlighting the rapid growth from the convergence of technology and healthcare ROCHESTER, Mich. , April 05, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions

PDF Version
March 15, 2022 at 8:00 AM EDT

Summary Toggle OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform

OptimizeRx expands reach of its point-of-care solutions to simplify the prescribing process of specialty medications for healthcare providers, and to enable greater access for patients ROCHESTER, Mich. , March 15, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading

PDF Version
March 7, 2022 at 8:00 AM EST

Summary Toggle OptimizeRx to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022

ROCHESTER, Mich. , March 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy today announced that its senior vice president of corporate finance, Andy D’Silva, will

PDF Version
February 24, 2022 at 4:01 PM EST

Summary Toggle OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum

Fourth quarter revenue Up 24% to $20.3 million , gross profit margin of 61% Introduction of key performance indicators (KPIs) representing “land and expand” strategy with key customer accounts Cash flow positive from operations of $0.7 million in 2021 ROCHESTER, Mich. , Feb.

PDF Version
February 22, 2022 at 8:00 AM EST

Summary Toggle Top 10 Pharma Deploys OptimizeRx’s Digital Access Solution to Streamline Patient Therapy Initiation Challenges

This is OptimizeRx’s largest enterprise-scale therapy initiation program launch to date ROCHESTER, Mich. , Feb. 22, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today

PDF Version
February 15, 2022 at 8:00 AM EST

Summary Toggle OptimizeRx Announces Preliminary Fourth Quarter 2021 Financial Results, Introduces New Key Performance Indicators and Provides Initial 2022 Guidance

ROCHESTER, Mich. , Feb. 15, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced preliminary unaudited financial and operational results for the three months

PDF Version
February 10, 2022 at 8:00 AM EST

Summary Toggle OptimizeRx Sets Fourth Quarter and Full Year 2021 Conference Call for Thursday, February 24 at 4:30 p.m. ET

ROCHESTER, Mich. , Feb. 10, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Thursday, February 24, 2022, at 4:30 p.m.

PDF Version
February 7, 2022 at 8:00 AM EST

Summary Toggle OptimizeRx CEO, William Febbo, to Speak at the Bank of America Annual HCIT and Digital Health Conference

ROCHESTER, Mich. , Feb. 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that Will Febbo , OptimizeRx’s CEO, will participate in the upcoming Bank of

PDF Version
February 1, 2022 at 8:00 AM EST

Summary Toggle OptimizeRx’s Mike Rousselle Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars

ROCHESTER, Mich. , Feb. 01, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced its vice president of data product, Mike Rousselle , has been named to MM+M’s

PDF Version
January 31, 2022 at 8:00 AM EST

Summary Toggle OptimizeRx to Participate in Upcoming February Investor Conferences

ROCHESTER, Mich. , Jan. 31, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy announced today that members of its leadership team will attend and present at the upcoming 11th

PDF Version